Related Experiment Video

Updated: Sep 5, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators

Jean-Bernard Lazaro1, Peter J Bailey, Andrew B Lassar

  • 1Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Genes & Development
|July 20, 2002
PubMed

Insights

Cyclin D-CDK4 activity suppresses skeletal muscle differentiation by inhibiting MEF2 transcriptional regulators. This occurs by blocking MEF2C

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • D-type cyclin-CDK4 complexes are active in proliferating cells and can inhibit skeletal muscle differentiation.
  • MEF2 family proteins are critical transcriptional regulators of skeletal muscle gene expression.

Purpose of the Study:

  • To investigate the mechanism by which cyclin D-CDK4 complexes suppress skeletal muscle differentiation.
  • To elucidate the role of MEF2 and its coactivator GRIP-1 in this process.

Main Methods:

  • Investigated the interaction between cyclin D-CDK4, MEF2, and GRIP-1 in myoblasts.
  • Utilized co-transfection assays to assess transcriptional activity and protein localization.
  • Examined the subnuclear localization of GRIP-1 and MEF2C under different cellular conditions.

Main Results:

  • Cyclin D-CDK4 activity inhibits MEF2 transcriptional activity by preventing the association of MEF2C with the coactivator GRIP-1.
  • GRIP-1 normally localizes to punctate nuclear structures during differentiation, tethering MEF2.
  • Ectopic cyclin D-CDK4 expression disrupts the localization of GRIP-1 and MEF2C to these nuclear structures, impairing differentiation.

Conclusions:

  • Cyclin D-CDK4 activity represses skeletal muscle differentiation in proliferating cells.
  • This repression mechanism involves the disruption of MEF2-GRIP-1 complex formation and localization to specific nuclear subdomains.
  • Understanding this pathway offers insights into the regulation of muscle development and potential therapeutic targets.

More Related Videos

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...